• Losartan Workflows for Hypertension Research

  2026-09-02

  Build more informative hypertension and vascular assays with Losartan, a selective angiotensin II receptor antagonist that enables receptor-level interrogation of AT1 signaling. This guide connects vascular smooth muscle experiments with emerging podocyte-protection research while emphasizing practical dosing, controls, and troubleshooting.

• Okadaic acid: PP1/PP2A Inhibition Guide

  2026-09-01

  Okadaic acid (A4540) provides nanomolar inhibition of PP2A and PP1 for testing phosphorylation-dependent signaling and apoptosis-related endpoints. It is suited to controlled biochemical and cell-based experiments, but not to broad phosphatase inhibition, therapeutic use, or mechanistic conclusions based on apoptosis alone.

• Dexamethasone (DHAP): Time-Resolved Assay Design

  2026-09-01

  Dexamethasone is a glucocorticoid anti-inflammatory reagent whose biological effects depend strongly on exposure timing, cell state, and endpoint selection. This guide presents a time-resolved framework for studying NF-κB regulation, neuroinflammation, stem cell differentiation, autophagy, and RhoB biology with clearer causal interpretation.

• Angiotensin (1-7): Mechanism and Research Use

  2026-08-31

  Angiotensin (1-7), also known as Asp-Arg-Val-Tyr-Ile-His-Pro, is an endogenous heptapeptide that signals mainly through Mas and counter-regulates selected angiotensin II responses. The A1041 research reagent combines a defined peptide sequence with reported purity above 99.7%, water and DMSO solubility specifications, and preclinical model benchmarks.

• Periodontopathogens Redirect Angiotensin I to Ang-(1-7)

  2026-08-31

  The reference study shows that Porphyromonas gingivalis and Tannerella forsythia can reshape local renin–angiotensin system chemistry through surface-associated PepO metalloproteases that hydrolyze angiotensin I toward Angiotensin (1-7). Structural, biochemical, cellular, and infection-model data connect bacterial protease specificity with a potentially important mechanism linking periodontitis to host peptide signaling.

• Captopril Workflows for ACE Inhibition Research

  2026-08-30

  Use Captopril to connect quantitative ACE inhibition with hypertension research, bradykinin-sensitive gut motility assays, and exploratory cancer studies. This workflow emphasizes assay controls, concentration logic, solution stability, and the critical distinction between upstream ACE blockade and direct B2-receptor pharmacology.

• NF 449: Selective P2X1 Platelet Research Tool

  2026-08-29

  NF 449 combines exceptionally potent P2X1 antagonism with a mechanistically important Gαs-selective profile, making it useful for separating ATP-driven platelet signaling from broader purinergic effects. This guide outlines practical platelet workflows, assay controls, comparative applications, and troubleshooting strategies for reproducible antithrombotic agent research.

• Go 6983: PKC Signaling Workflow Guide

  2026-08-28

  Go 6983 is a practical pan-PKC inhibitor for resolving isoform-sensitive signaling, phorbol ester responses, and pathway-linked phenotypes in cancer progression studies. This guide combines dose-controlled PKC workflows with metabolism-aware assay design inspired by recent human blastoid research.

• BFH772 (VEGFR2 inhibitor): Use Guide

  2026-08-28

  BFH772 is a selective VEGFR2 kinase inhibitor for controlled studies of VEGFR2 signaling, endothelial responses, and tumor angiogenesis. It is best suited to organic-solvent-based workflows and should not be used where water solubility, broad kinase inhibition, or direct clinical efficacy evidence is required.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-27

  Oliveira et al. report that naturally occurring angiotensin fragments can increase the binding of SARS-CoV-2 spike protein to host-cell receptors, with the strongest activity observed for shorter, N-terminally truncated peptides. The study identifies peptide structure, especially modifications around tyrosine, as a potential determinant of spike–receptor interactions while also highlighting the need for cellular and in vivo validation.

• S63845 MCL1 Inhibitor: Apoptosis Workflow

  2026-08-27

  S63845 provides a selective way to test whether cancer cells depend on MCL1-mediated restraint of mitochondrial apoptosis. This workflow combines dose-response profiling with BAX/BAK, cytochrome c, caspase, PARP, and LACTB-aware readouts to distinguish pathway engagement from nonspecific toxicity.

• Captopril ACE Inhibitor: Workflows & Troubleshooting

  2026-08-26

  Captopril supports reproducible ACE inhibition in hypertension research while offering a practical probe for apoptosis induction in cancer cells and peptide-mediated gastrointestinal assays. This guide connects concentration planning, Angiotensin I-versus-II controls, and bradykinin B2 receptor experiments without overstating what the reference study directly demonstrated.

• BAPTA-AM: Calcium Chelation Workflows

  2026-08-26

  BAPTA-AM provides a practical way to test whether intracellular Ca²⁺ is a driver rather than a bystander in neuronal injury, apoptosis, and channel physiology. This guide combines concentration-controlled loading, calcium imaging, pathway-level validation, and troubleshooting for more interpretable experiments.

• Berbamine hydrochloride: NF-κB Assay Workflows

  2026-08-25

  Berbamine hydrochloride supports phenotype-to-mechanism workflows that connect viability, STAT3, calcium homeostasis, NF-κB signaling, and ferroptosis-related readouts. This guide shows how to use it as a carefully controlled perturbation tool in leukemia and hepatocellular carcinoma models without overstating pathway selectivity.

• Diminazene Aceturate: A Two-Axis Research Framework

  2026-08-25

  Diminazene Aceturate is a trypanocidal research compound with applications spanning parasite assays and ACE2 activation research. This guide develops an assay-centered framework for interpreting its chemistry, mitochondrial findings, controls, and experimental limitations.

7729 records 1/516 page Next 12345 下5页 Last page